John Rim, Samsung Biologics CEO
Samsung’s CDMO arm commits to $324M land purchase for a second bio campus
As investments into CDMOs are gaining steam from several South Korean and Japanese conglomerates, Samsung is making a big land grab.
On Monday, Samsung Biologics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.